WO2009102152A2 - 천연물을 이용한 발효물의 제조 방법 및 상기 방법에 의해 제조된 발효물을 포함하는 식품 또는 의약품 - Google Patents
천연물을 이용한 발효물의 제조 방법 및 상기 방법에 의해 제조된 발효물을 포함하는 식품 또는 의약품 Download PDFInfo
- Publication number
- WO2009102152A2 WO2009102152A2 PCT/KR2009/000656 KR2009000656W WO2009102152A2 WO 2009102152 A2 WO2009102152 A2 WO 2009102152A2 KR 2009000656 W KR2009000656 W KR 2009000656W WO 2009102152 A2 WO2009102152 A2 WO 2009102152A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- product
- fermentation
- content
- natural
- nucleic acid
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 28
- 239000003814 drug Substances 0.000 title abstract description 13
- 239000005445 natural material Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title description 9
- 238000000034 method Methods 0.000 claims abstract description 48
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 41
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 38
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 22
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 6
- 238000000855 fermentation Methods 0.000 claims description 84
- 230000004151 fermentation Effects 0.000 claims description 83
- 229930014626 natural product Natural products 0.000 claims description 58
- 102000039446 nucleic acids Human genes 0.000 claims description 36
- 108020004707 nucleic acids Proteins 0.000 claims description 36
- 150000007523 nucleic acids Chemical class 0.000 claims description 35
- 244000005700 microbiome Species 0.000 claims description 29
- 240000005979 Hordeum vulgare Species 0.000 claims description 27
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 27
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 235000007238 Secale cereale Nutrition 0.000 claims description 11
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 11
- 239000000796 flavoring agent Substances 0.000 claims description 11
- 235000019634 flavors Nutrition 0.000 claims description 11
- 235000007319 Avena orientalis Nutrition 0.000 claims description 9
- 244000075850 Avena orientalis Species 0.000 claims description 9
- 240000006394 Sorghum bicolor Species 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 244000082988 Secale cereale Species 0.000 claims description 7
- 241000209140 Triticum Species 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 244000062793 Sorghum vulgare Species 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 244000017020 Ipomoea batatas Species 0.000 claims description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 2
- 230000009089 cytolysis Effects 0.000 claims description 2
- 235000019713 millet Nutrition 0.000 claims description 2
- 238000000527 sonication Methods 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 238000010564 aerobic fermentation Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract 3
- 239000000047 product Substances 0.000 description 49
- 208000008589 Obesity Diseases 0.000 description 24
- 235000020824 obesity Nutrition 0.000 description 24
- 208000001145 Metabolic Syndrome Diseases 0.000 description 18
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 18
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 17
- 235000014633 carbohydrates Nutrition 0.000 description 17
- 235000018102 proteins Nutrition 0.000 description 12
- 239000003925 fat Substances 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 235000012054 meals Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000209056 Secale Species 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000223218 Fusarium Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- -1 etc. Chemical compound 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000001596 intra-abdominal fat Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000567178 Fusarium venenatum Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000593344 Rhizopus microsporus Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000235088 Saccharomyces sp. Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 230000034149 carbohydrate storage Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 108010075550 termamyl Proteins 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000037221 weight management Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention is to reduce the carbohydrate content of natural products, fermentation by adding microorganisms to increase the content of beta glucan, the fermentation of natural products with a nucleic acid content of 3-4g or less based on the protein content of 70g or dietary fiber content of 24g
- the present invention relates to a method for producing water, a natural product fermented product produced by the method, and a food or pharmaceutical product containing the natural product fermented product.
- beta glucan has the function of reducing the weight of visceral fat and reducing the size of visceral fat cells. It is also effective in reducing triglyceride content in the body (Soon Ah Kang et al., 2002, J. Korean Soc.Food Sci.Nutr. 31 (6), 1052-1057; Ho-Moon Seog et al. , 2002, Korean J. Food Sci.Technol.Vol 34, No 4, PP 678-683; Jue Li, Takashi Kaneko et al., Metabolism, Vol 52, No 9 (September), 2003, pp1206-1210).
- the present invention has been made in accordance with the above-described demands, the disadvantages of natural products that are very good for people suffering from obesity and metabolic syndrome, or want to prevent the accumulation of beta glucan through the microbial fermentation instead of raising the content of the body Foods or drugs characterized by high beta glucan content, relatively low calorie and carbohydrate content, and low fat produced by a process that controls the nucleic acid so as to reduce the content of easy carbohydrates, increase the taste and at the same time consume a large amount of food.
- the present invention provides a method for producing a natural fermentation product to ferment by adding a microorganism to the natural product, increase the content of beta glucan, instead of reducing the content of carbohydrate, and controls the content of the nucleic acid.
- the present invention also provides a natural product fermentation produced by the above method.
- the present invention provides a food or drug comprising the natural product fermentation.
- a variety of natural products that have been treated as low-level foods in comparison with other foods have a high content of beta glucan and have a very good taste, and a very high level of satiety even when consumed less. You can switch to a product.
- ultra low-calorie products based on dietary fiber including beta glucan can be made, and patients with mild obesity and metabolic syndrome, or those who want to prevent In order to produce products containing both dietary fiber and beta-glucan at the same time, it can be widely used as a regular meal substitute.
- a method for producing a natural fermentation product with reduced carbohydrate content and increased beta glucan content including controlling the nucleic acid during or after fermentation.
- Carbohydrate content is characterized in that it comprises the step of imparting texture and flavor to the concentrated or dried fermentation, and the beta glucan content provides a method for producing a natural product fermentation.
- the method for producing a natural product fermentation product of the present invention may further comprise the step of saccharifying after grinding and liquefying the natural product.
- the method for producing a natural product fermentation product of the present invention includes the step of fermentation by adding an edible microorganism to the natural product.
- Edible microorganisms and the like fungi, yeast, bacteria, fungus Fusarium (Fusarium) and the genus, genus Aspergillus spread Ruth (Aspergillus), such as in Rizzo crispus (Rhizopus), yeast Mai Seth (Saccharomyces) in a Saccharomyces and the like, such as bacteria include, but are in Bacillus (Bacillus), but is not limited thereto.
- the edible microorganism is specifically, Fusarium venenatum , Aspergillus oryzae , Aspergillus awamori , Rhizopus microsporus , Saccharomyces Saccharomyces cerevisiae , Bacillus megaterium , Bacillus subtilis , and the like, but are not limited thereto.
- the microorganism is yeast, more preferably Saccharomyces cerevisiae .
- the fermentation method using the microorganism may vary depending on the microorganism used, fermentation conditions and fermentation medium, and fermentation conditions and fermentation medium may be those known in the art.
- yeast can be cultured at 30 ° C. in YPD medium and aerobic conditions can be selected as needed.
- the natural product may be barley, wheat, rye, rye, sorghum, oats, rice, corn, barley, crude, millet, potatoes, sweet potatoes and the like, but is not limited thereto.
- the natural products may be mixed with each other or mixed with other natural products.
- the natural product may include a water-soluble component and a non-water-soluble component.
- the non-water-soluble component may reduce the taste, if necessary ferment it may improve the taste, digestion and absorption, and may be a good component during fermentation.
- the natural product before fermenting the natural product, it can be separated into a water-soluble substance and a non-water-soluble substance and fermented only to the water-soluble substance, and the separated non-water-soluble substance can be combined with the fermentation product after the fermentation step.
- Fermentation with water-soluble materials only improves fermentation efficiency by smoothing the agitation and air flow in the fermentation tube, and removes microorganisms from fermented products after fermentation is completed to control the content of nucleic acid. It can prevent the material from separating.
- the method of the present invention includes the step of controlling the nucleic acid in the fermentation process or after completion of the fermentation.
- Methods of controlling nucleic acids include a method of completing fermentation by minimizing the amount of microorganisms produced during the fermentation process and a method of lowering the content of the microorganisms by partially or completely removing the fermentation products after the fermentation is completed.
- One of the methods for minimizing the amount of microorganisms produced during the fermentation process is to ferment while maintaining a relatively high carbon / N ratio.
- the carbon ratio is in the range of 12.1-31.9.
- fermentation rarely occurs at an early stage, and it takes a very long time for the fermentation to be completed. For example, it takes up to 96 hours for fermentation to complete in 48 hours.
- nucleic acids can be removed by direct treatment of fermented fermented products.
- the methods include laser irradiation, heat shocking, sonication, and alkaline lysis. This is not restrictive.
- nucleic acid is also very low, obese people with metabolic syndrome can eat food with confidence.
- beta glucans and other ingredients are compared with other grains as follows. In addition, it was confirmed that the content ratio of each ingredient could vary according to the level, variety and moisture content of the grains.
- Barley has the advantages of abundant dietary fiber and high beta glucan content, relatively low calorie content, almost no fat content, and has a medium protein content, high carbohydrate content, hard digestion, and poor taste. There is this.
- the fermentation process through microorganisms reduces the content of carbohydrates that accumulate well in the body, increases the content of beta glucan, which can prevent and treat obesity and metabolic syndrome, improve digestion, and dramatically improve taste and flavor. I tried to solve the problem.
- the crushed barley is liquefied, saccharified and added to the fermentation process. If necessary, the saccharification step may be omitted.
- microorganisms used are yeasts that are already safe and are known to be very useful to humans.
- nucleic acid After fermentation, control the nucleic acid by separating the yeast with a centrifuge or by selecting a fermentation method that minimizes the microbial cell mass. In addition, the nucleic acid may be controlled by directly treating the fermented product.
- the food or medicine is completed by giving texture and flavor to fermented products.
- the process may be concentrated or dried.
- Raw materials-grinding-liquefaction-saccharification (omittable)-water-soluble and non-water-soluble components, fermentation-yeast separation-yeast separation solution and non-water-soluble components combined-concentrated or dry-gives texture and flavor
- Raw materials-grinding-liquefaction-saccharification can be omitted)-separated into water-soluble components and those that are not fermentation only water-soluble components-yeast separation-concentration or drying-texture and flavor
- the target product is ingested for obese people or at risk of obesity, or for those with metabolic syndrome, mainly for weight management and abdominal fat management, which can prevent many risks from increased uric acid when consumed in large quantities.
- Nucleic acid must be controlled to ensure that In particular, gout patients must strictly limit the intake of high-purine nucleic acid nucleic acid control step of the developed food is essential.
- the recommended daily intake of dietary fiber is 24g and the recommended daily intake of protein is about 70g, so the maximum limit of relative nucleic acid content can be easily calculated when the final product is finished.
- the degree of control of nucleic acid and the method of control may vary depending on the formulation of the final product, and if a nucleic acid control process is selected that separates the yeast from the fermentation, some useful substances may be removed together due to the nature of the process.
- yeast is 7 times higher than sardines, which are one of the foods with the highest nucleic acid, and are about 6-12% by dry weight. It is known.
- the ratio can be changed to various products according to the needs of the final finished product.
- the components may be combined after concentration or drying, may be concentrated or dried after being combined, or may be re-dried after concentrating or drying only one of them.
- Texturization of the finished or concentrated product can be processed using a variety of methods, such as meat texture, bread texture, and snack texture.
- the step of giving a texture can be made by extrusion molding.
- Raw material composition ratio, raw material input, moisture content, screw rotation speed, barrel heating temperature can be controlled during extrusion molding.
- by increasing the content of water to about 40% by extrusion molding can be extruded at a pressure of 100-1000 psi under a temperature condition of 100-170 °C. Cooling dies or circular dies can be used for protein texture.
- the present invention provides a natural product fermentation product with reduced carbohydrate content and increased beta glucan content produced by the method for producing a natural product fermentation product of the present invention.
- the natural product fermentation product includes fermentation products which are fermented by edible microorganisms and whose nucleic acid is controlled. Control of edible microorganisms, natural products and nucleic acids is as described above.
- the present invention also provides a product comprising the natural product fermentation product of the present invention.
- the product may be a food or medicine.
- the food or medicament of the present invention may consist of the natural product fermentation itself or may contain other additives.
- Additions may include, but are not limited to, proteins, fats, carbohydrates, dietary fiber, betaglucans, inorganic salts, or vitamins.
- Additives may be used in the fermentation process of the present invention, and inorganic salts include MgCl 2 , KCl, NaCl, Ca-lactate, ammonium citrate, and the like.
- Vitamins B 1 , vitamin B 2 , and vitamin B 6 , Nicotinic acid amide, vitamin C, etc., and nitrogen sources include sodium nitrate (NaNO 3 ), ammonia water (NH 4 OH), ammonium carbonate ((NH 4 ) 2 CO 3 ), ammonium chloride (NH 4 Cl), ammonium phosphate ( (NH 4 ) 2 HPO 4 ), peptone, soytone, tryptone, yeast extract, soy meal, malt extract, etc. This is not restrictive.
- the product according to an embodiment of the present invention is characterized in that the nucleic acid content of 3-4g or less based on the protein content of 70g or dietary fiber content of 24g. It is known that the daily recommended intake of protein is 70g, the recommended daily intake of dietary fiber is about 24g, and since the UN's recommended daily intake of nucleic acids is about 3-4g, the product of the present invention is based on 70g of protein or 24g of dietary fiber. It is preferable that the content is 3-4 g or less.
- Food or medicine according to one embodiment of the present invention can be used for the prevention and treatment of obesity and metabolic syndrome. Since the food or medicine of the present invention is characterized by being delicious, full and fat, it is possible to prevent or treat obesity and metabolic syndrome.
- Fermentation products of the present invention can be fermented using any microorganism, it is possible to improve the taste of natural products by fermentation using the microorganisms.
- the microorganism is yeast
- the natural product may be barley, oats, rye, rye wheat, sorghum and mixtures containing them.
- the beta glucan content based on the total weight of the product is 0.26-1.0 wt% or more when the natural product is sorghum or a mixture containing sorghum, and includes lymil or lymil Preferably at least 0.34-1.2% by weight, in the case of a mixture containing rye or rye, at least 1.48-2.4% by weight.
- a mixture containing sorghum is meant to include barley, tapioca and the like in sorghum.
- the beta glucan content based on the total weight of the product is 2.5-5.7% by weight or more when the natural product is oats or a mixture containing oats, barley or a mixture containing barley In the case of, it is preferable that it is 4.09-6.3 wt% or more.
- the product of the present invention may further contain beta glucan.
- the product of the present invention it is preferable that the protein content of the product is increased than the protein content of natural products before fermentation.
- Biochemical changes to ingredients that negatively affect the taste and fart can significantly improve the properties of food. Since one of the causes of farts is that gas is generated as the polysaccharides that are not digested or absorbed in the small intestine are fermented by the microorganisms in the large intestine, a part of the polysaccharides is biochemically changed by the microorganisms through the fermentation process. This reduces the occurrence of farts in the human body than ingesting natural products by themselves.
- the ground barley was dissolved to a final solids concentration of 13.8% and forcedly stirred until the solution was homogenized.
- the pH was adjusted to 6.3 and 1% of ⁇ -amylase (Termamyl 120L) was added on the basis of barley solids and reacted for 3 hours in a 95 ° C constant temperature water bath.
- amyloglucosidase (AMG 300L) was added 2% based on barley solids for saccharification, and stirred for 20 hours in a 62 ° C reaction bath.
- the saccharified solution prepared in the liquefaction saccharification process was centrifuged at 4,910 ⁇ g for 10 minutes (MF 600, Hanil Science Industrial Co., Korea) and separated into 17% non-soluble and 83% water-soluble portions by weight.
- Strains used in the present invention are bakery yeast (Saccharomyces sp.) Glucose 2% (w / v), peptone 2% (w / v), yeast extract 1% (w / v), agar 1.5% (w / v Incubated in YPD solid medium consisting of 25 °C, 4 days cycle.
- the primary seed culture was a YPD liquid medium (250 ml triangle) consisting of part of the yeast cells in YPD solid medium consisting of 2% glucose (w / v), 2% peptone (w / v) and 1% (w / v) yeast extract. Flask, 50ml working volume) and incubated for 24 hours at 30 °C, 150rpm conditions.
- seedlings cultured in the primary seed culture were inoculated in 1% (v / v) of YPD liquid medium and incubated at 30 ° C. and 150 rpm for 12 hours.
- This culture was used 5L fermentation tank (Liflus GX, Biotron, KOREA). Sterilization conditions were carried out at 121 °C 20 minutes. Incubate the secondary seed culture 1% (v / v) in 2Kg of medium (8% saccharification solution + 4% soytone) made by adding organic nitrogen source (soytone) to the sample produced by the liquefaction saccharification process, and incubation temperature 30 °C, stirring speed 48 hours at 250rpm, aeration rate 1 vvm conditions to produce a fermentation broth with a concentration of 21.5g / L on the basis of dry yeast weight. PH control in culture was adjusted to pH 5.5 using 28% NH 4 OH and 1N HCl.
- the yeast fermentation broth prepared in this culture was centrifuged at 4,910 x g for 10 minutes (MF 600, Hanil Science Industrial Co., Korea) to obtain 9% yeast solution and 91% supernatant by weight.
- the supernatant from which the yeast was removed was concentrated to a solid content concentration of 20% using a reduced pressure concentrator (N 3000, Eyela, Japan) at 55 ° C heating temperature conditions.
- the non-aqueous portion and the fermentation concentrate from which the yeast was removed were mixed in the non-aqueous portion and the water-soluble portion separation process.
- the mixed solution made with a solid concentration of 23% was dried using a spray dryer (SD-1000, Eyela, Japan) to a solid concentration of 95% at a temperature of 160 ° C of hot air (inlet) and 95 ° C of outlet air.
- the dried sample was molded through a twin screw extrusion machine at a barrel heating temperature of 140 ° C., and cooled using a cooling die.
- zucchini, potato and seaweed (or kelp) extract was added to double the flavor, taste and function to the organized samples, and the spices were added separately to extrude at high temperature and high pressure to make the final product.
- the finished product is significantly reduced in carbohydrate content, compared to the raw barley, it can be seen that the content of dietary fiber and beta glucan significantly increased.
- Nucleic acid content is also well below the acceptable level, and protein content is also above the appropriate level can be used as a regular meal replacement.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cereal-Derived Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
구분 | 보리 | 귀리 | 조 | 수수 |
탄수화물 | 64.0 | 57.0 | 68.0 | 66.1 |
지방 | 2.1 | 4.7 | 3.9 | 2.8 |
단백질 | 12.0 | 14.3 | 9.7 | 9.6 |
섬유소 | 11.2 | 10.7 | 8.0 | 10.3 |
곡종 | Anderson 등 (1978) | Henry (1985) | Joergensen 등 (1988) | McCleary와 Glennie-Holmes (1985) | Prentice 등 (1980) | 이 등 (2001) |
보리 | 5.01 | 4.36 | 4.09 | 4.43 | 6.3 | 4.45 |
귀리 | 2.50 | 3.37 | 3.27 | 4.08 | 5.7 | 3.54 |
쌀 | 0.13 | 0.10 | - | 0.04 | - | - |
밀 | 0.54 | 0.65 | 0.48 | 0.60 | 1.4 | 0.54 |
호밀 | 1.93 | 1.89 | 1.48 | 1.65 | 2.4 | 1.53 |
라이밀 | 0.34 | 0.65 | 0.70 | 0.51 | 1.2 | - |
수수 | - | - | 0.26 | - | 1.0 | - |
옥수수 | - | - | <0.00 | 0.12 | - | - |
구분 | 탄수화물 | 지방 | 단백질 | 식이섬유(베타글루칸) | 핵산 |
원료 보리 | 64.0 | 2.1 | 12.0 | 11.2(5.5) | 0.4 |
완성 제품 | 28.1 | 2.2 | 36.1 | 21.2(8.1) | 0.5 |
Claims (20)
- 천연물에 식용 가능한 미생물을 첨가하여 발효하는 단계; 및발효 과정에서 또는 발효 완료 후 핵산을 제어하는 단계를 포함하는 탄수화물 함량은 감소하고, 베타글루칸 함량은 증가된 천연물 발효물의 제조 방법.
- 제1항에 있어서,천연물을 분쇄 및 액화시키는 단계;상기 분쇄 및 액화된 천연물에 식용 가능한 미생물을 첨가하여 발효하는 단계;발효 과정에서 또는 발효 완료 후 핵산을 제어하는 단계;상기 핵산이 제어된 발효물을 농축 또는 건조하는 단계; 및상기 농축 또는 건조된 발효물에 조직감 및 향미를 부여하는 단계를 포함하는 것을 특징으로 하는 탄수화물 함량은 감소하고, 베타글루칸 함량은 증가된 천연물 발효물의 제조 방법.
- 제2항에 있어서, 상기 천연물을 분쇄 및 액화시킨 후에 당화 공정을 추가로수행하는 것을 특징으로 하는 방법.
- 제1항에 있어서, 천연물을 발효하기 전에 수용성 물질과 비 수용성 물질로 분리하고 수용성 물질만을 대상으로 발효하는 것을 특징으로 하는 방법.
- 제4항에 있어서, 상기 분리된 비 수용성 물질을 발효 단계 후에 발효물과 합하는 것을 특징으로 하는 방법.
- 제1항에 있어서, 상기 식용 가능한 미생물은 효모인 것을 특징으로 하는 방법.
- 제1항에 있어서, 상기 발효는 호기성 발효인 것을 특징으로 하는 방법.
- 제1항에 있어서, 상기 발효는 미생물 생성량을 최소화하는 것을 특징으로 하는 방법.
- 제1항에 있어서, 핵산을 제어하는 단계는 발효 완료된 물질에서 미생물을 일부 제거하거나 또는 완전 제거하는 것을 특징으로 하는 방법.
- 제1항에 있어서, 핵산을 제어하는 단계에서 발효물에 레이저 조사(laser irradiation), 열처리(heat shocking), 초음파처리(sonication), 또는 알칼리 용해(alkaline lysis)를 수행하는 것을 특징으로 하는 방법.
- 제1항에 있어서, 상기 천연물은 보리, 밀, 라이밀, 호밀, 수수, 귀리, 쌀, 옥수수, 율무, 조, 기장, 감자 및 고구마로 이루어진 군으로부터 선택되는 것을 특징으로 하는 방법.
- 제1항 내지 제11항 중 어느 한 항의 방법에 의해 제조된 탄수화물 함량은 감소하고, 베타글루칸 함량은 증가된 천연물 발효물.
- 제12항에 따른 천연물 발효물을 포함하는 제품.
- 제13항에 있어서, 상기 제품이 식품 또는 의약품인 것을 특징으로 하는 제품.
- 제13항에 있어서, 단백질, 지방, 탄수화물, 식이섬유, 베타글루칸, 무기염류 또는 비타민을 추가로 함유한 제품.
- 제13항에 있어서, 제품의 단백질 함량 70g 또는 식이섬유 함량 24g 기준으로 핵산의 함량이 3-4g 이하인 제품.
- 제13항에 있어서, 제품의 총 중량% 기준으로 베타글루칸 함량은 상기 천연물이 수수 또는 수수가 포함된 혼합물인 경우에 0.26-1.0 중량% 이상이며, 라이밀 또는 라이밀이 포함된 혼합물인 경우에 0.34-1.2 중량% 이상이며, 호밀 또는 호밀이 포함된 혼합물인 경우에 1.48-2.4 중량% 이상인 제품.
- 제13항에 있어서, 제품의 총 중량% 기준으로 베타글루칸 함량은 상기 천연물이 귀리 또는 귀리가 포함된 혼합물인 경우에 2.5-5.7 중량% 이상이며, 보리 또는 보리가 포함된 혼합물인 경우에 4.09-6.3 중량% 이상인 제품.
- 제17항 또는 제18항에 있어서, 제품의 단백질 함량이 발효 전 천연물의 단백질 함량보다 증가된 제품.
- 제17항 또는 제18항에 있어서, 베타글루칸을 추가로 함유한 제품.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2714793A CA2714793A1 (en) | 2008-02-14 | 2009-02-12 | Method for producing fermented product using natural material, and food or medicine containing fermented product made from same |
BRPI0907875-4A BRPI0907875A2 (pt) | 2008-02-14 | 2009-02-12 | Produto fermentado produzido por adição de microorganismo comestível e método para produzir produto fermentado |
US12/865,447 US20100310716A1 (en) | 2008-02-14 | 2009-02-12 | Method for producing fermented product using natural material, and food or medicine containing fermented product made from same |
MX2010008879A MX2010008879A (es) | 2008-02-14 | 2009-02-12 | Metodo para producir un producto fermentado usando material natural, y alimento o medicina que contiene el producto fermentado hecho a partir de el. |
AU2009213253A AU2009213253A1 (en) | 2008-02-14 | 2009-02-12 | Method for producing fermented product using natural material, and food or medicine containing fermented product made from same |
CN200980104600XA CN101938914A (zh) | 2008-02-14 | 2009-02-12 | 使用天然材料生产发酵产品的方法以及含有由此制备的发酵产品的食物或药物 |
EP09709828A EP2241199A4 (en) | 2008-02-14 | 2009-02-12 | PROCESS FOR PRODUCING FERMENTED MATERIAL USING NATURAL MATERIAL AND FOOD OR MEDICINE CONTAINING THE FERMENTED MATERIAL THUS PRODUCED |
JP2010546695A JP2011512135A (ja) | 2008-02-14 | 2009-02-12 | 天然物の発酵物及びその製造方法 |
IL207606A IL207606A0 (en) | 2008-02-14 | 2010-08-12 | Method for producing fermented product using natural material, and food or medicine containing fermented product made from same |
ZA2010/06549A ZA201006549B (en) | 2008-02-14 | 2010-09-13 | Method for producing fermented product using natural material,and food or medicine containing fermented product made from same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2008-0013299 | 2008-02-14 | ||
KR20080013299 | 2008-02-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009102152A2 true WO2009102152A2 (ko) | 2009-08-20 |
WO2009102152A3 WO2009102152A3 (ko) | 2009-11-26 |
Family
ID=40957380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2009/000656 WO2009102152A2 (ko) | 2008-02-14 | 2009-02-12 | 천연물을 이용한 발효물의 제조 방법 및 상기 방법에 의해 제조된 발효물을 포함하는 식품 또는 의약품 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100310716A1 (ko) |
EP (1) | EP2241199A4 (ko) |
JP (1) | JP2011512135A (ko) |
KR (2) | KR100952355B1 (ko) |
CN (1) | CN101938914A (ko) |
AU (1) | AU2009213253A1 (ko) |
BR (1) | BRPI0907875A2 (ko) |
CA (1) | CA2714793A1 (ko) |
IL (1) | IL207606A0 (ko) |
MX (1) | MX2010008879A (ko) |
RU (1) | RU2453150C2 (ko) |
WO (1) | WO2009102152A2 (ko) |
ZA (1) | ZA201006549B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101904087B1 (ko) | 2017-03-30 | 2018-10-05 | 주식회사 포스팜 | 염증 질환의 치료 또는 예방에 유효한 수수 발효물 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101282371B1 (ko) * | 2010-01-08 | 2013-07-04 | 한아름영농조합법인 | 자색고구마 추출물 발효액을 유효성분으로 함유하는 지방 생성 및 축적 저해용 조성물 |
WO2012011741A2 (ko) * | 2010-07-20 | 2012-01-26 | 한국생명공학연구원 | 신규한 푸사리세틴 화합물 및 이의 용도 |
KR101220815B1 (ko) * | 2010-12-07 | 2013-01-10 | 계명대학교 산학협력단 | 곡류 분말 발효물 제조방법 및 이에 따른 곡류 분말 발효물 |
ITMI20111488A1 (it) * | 2011-08-03 | 2013-02-04 | Gnosis Spa | Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita' |
KR101343944B1 (ko) * | 2011-12-29 | 2013-12-24 | 샘표식품 주식회사 | 보리의 기능성 다당류를 증가시키는 방법 |
JP6080390B2 (ja) * | 2012-06-13 | 2017-02-15 | サッポロビール株式会社 | 麦類原料液及び飲料並びにこれらに関する方法 |
EP2700321A1 (en) * | 2012-08-24 | 2014-02-26 | Etablissements J. Soufflet | Aqueous food composition enriched in beta-glucan |
KR101376033B1 (ko) | 2013-12-04 | 2014-03-19 | 이광열 | 귀리 청국장의 제조 방법 |
US20160304924A1 (en) * | 2015-04-15 | 2016-10-20 | Kevin Henry Fortin | Synergistic food fermentation utilizing fungal mycelium and bacilli |
WO2017003263A1 (ko) * | 2015-07-01 | 2017-01-05 | (주) 위드바이오코스팜 | 신바이오틱 발효 산물의 제조 방법 및 이에 의하여 제조된 신바이오틱 발효산물 |
RU2611180C1 (ru) * | 2016-02-24 | 2017-02-21 | Общество с ограниченной ответственностью "Твин Технолоджи Компани" | Способ производства ферментированного продукта из зерновой культуры, содержащего пищевые волокна |
CN113573616A (zh) * | 2019-03-15 | 2021-10-29 | 皇家飞利浦有限公司 | 食物产品降糖 |
KR102339554B1 (ko) * | 2019-12-23 | 2022-02-25 | (주) 나우코스 | 오트밀과 알로에의 복합발효 추출물을 함유한 애완동물용 샴푸 조성물 |
KR102228332B1 (ko) * | 2020-09-01 | 2021-03-16 | 농업회사법인 주식회사 엘바이오텍 | 고함량 베타글루칸을 포함하는 고구마 발효물 및 이를 함유하는 면역개선 기능성 식품 조성물 |
KR102559796B1 (ko) * | 2021-07-27 | 2023-07-26 | 주식회사 로크 | 홍차추출물, 고구마발효물 및 커피식초를 이용한 크림타입형 화장료 조성물 및 이의 제조방법 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950002867B1 (ko) * | 1991-08-09 | 1995-03-27 | 주식회사 진로 | 보리기울로부터 수용성 베타글루칸을 생산하는 방법 및 그 이용 |
KR950002867A (ko) * | 1993-07-05 | 1995-02-16 | 이양순 | 액상물질의 도포로울러 |
AU754790B2 (en) * | 1998-10-26 | 2002-11-28 | Fibeer Ab | Preparation of wort and beer of high nutritional value, and corresponding products |
AU2001252219B2 (en) * | 2000-03-24 | 2006-02-09 | Societe Des Produits Nestle S.A. | Beta-glucans from filamentous fungi |
CA2345606A1 (en) * | 2000-09-27 | 2002-03-27 | The Governors Of The University Of Alberta | Grain fractionation |
FI20010780A0 (fi) * | 2001-04-12 | 2001-04-12 | Raisio Benecol Oy | Parannetut koostumukset |
US6835558B2 (en) * | 2002-02-04 | 2004-12-28 | General Mills, Inc. | Beta-glucan compositions and process therefore |
KR100873059B1 (ko) * | 2002-07-18 | 2008-12-09 | 주식회사 더멋진 바이오텍 | 베타글루칸의 지방축적 억제 용도 |
EP1608236B1 (en) * | 2003-04-02 | 2014-11-05 | Cargill, Incorporated | Improved dietary fiber containing materials comprising low molecular weight glucan |
JP4076901B2 (ja) * | 2003-04-21 | 2008-04-16 | アサヒビール株式会社 | 発酵麦芽飲料の製造方法 |
SE528537C2 (sv) * | 2003-11-24 | 2006-12-12 | Biovelop Internat Bv | Löslig dietfiber från havre- och kornsädeskorn |
CA2550771A1 (en) * | 2003-12-22 | 2005-07-21 | Sapporo Breweries Limited | Malt root of wheat, barley, oats or rye including high functional ingredients contents and their processing methods |
KR20060011238A (ko) * | 2004-07-29 | 2006-02-03 | (주)진바이오텍 | 발효대두분말을 이용한 효소를 함유한 건강식인 발효콩식 조성물과 다이어트를 위한 발효콩식 조성물 |
JP4684965B2 (ja) * | 2006-07-24 | 2011-05-18 | ヤヱガキ醗酵技研株式会社 | 機能性食品とその製造方法 |
JP5020740B2 (ja) * | 2007-08-22 | 2012-09-05 | 株式会社はくばく | β−グルカンを主体とする水溶性食物繊維を含有する食酢の製造方法 |
-
2009
- 2009-02-12 CA CA2714793A patent/CA2714793A1/en not_active Abandoned
- 2009-02-12 AU AU2009213253A patent/AU2009213253A1/en not_active Abandoned
- 2009-02-12 RU RU2010137972/13A patent/RU2453150C2/ru not_active IP Right Cessation
- 2009-02-12 KR KR1020090011391A patent/KR100952355B1/ko not_active IP Right Cessation
- 2009-02-12 BR BRPI0907875-4A patent/BRPI0907875A2/pt not_active IP Right Cessation
- 2009-02-12 WO PCT/KR2009/000656 patent/WO2009102152A2/ko active Application Filing
- 2009-02-12 EP EP09709828A patent/EP2241199A4/en not_active Withdrawn
- 2009-02-12 CN CN200980104600XA patent/CN101938914A/zh active Pending
- 2009-02-12 MX MX2010008879A patent/MX2010008879A/es unknown
- 2009-02-12 JP JP2010546695A patent/JP2011512135A/ja active Pending
- 2009-02-12 US US12/865,447 patent/US20100310716A1/en not_active Abandoned
-
2010
- 2010-03-16 KR KR1020100023107A patent/KR101103287B1/ko not_active IP Right Cessation
- 2010-08-12 IL IL207606A patent/IL207606A0/en unknown
- 2010-09-13 ZA ZA2010/06549A patent/ZA201006549B/en unknown
Non-Patent Citations (4)
Title |
---|
HO-MOON SEOG ET AL., KOREAN J. FOOD SCI. TECHNOL., vol. 34, no. 4, 2002, pages 678 - 683 |
JUE LI; TAKASHI KANEKO ET AL., METABOLISM, vol. 52, no. 9, 2003, pages 1206 - 1210 |
See also references of EP2241199A4 |
SOON AH KANG ET AL., J. KOREAN SOC. FOOD SCI. NUTR., vol. 31, no. 6, 2002, pages 1052 - 1057 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101904087B1 (ko) | 2017-03-30 | 2018-10-05 | 주식회사 포스팜 | 염증 질환의 치료 또는 예방에 유효한 수수 발효물 |
Also Published As
Publication number | Publication date |
---|---|
RU2453150C2 (ru) | 2012-06-20 |
EP2241199A2 (en) | 2010-10-20 |
IL207606A0 (en) | 2010-12-30 |
KR101103287B1 (ko) | 2012-01-11 |
KR20100049513A (ko) | 2010-05-12 |
CN101938914A (zh) | 2011-01-05 |
BRPI0907875A2 (pt) | 2015-07-21 |
CA2714793A1 (en) | 2009-08-20 |
AU2009213253A1 (en) | 2009-08-20 |
JP2011512135A (ja) | 2011-04-21 |
KR20090088318A (ko) | 2009-08-19 |
KR100952355B1 (ko) | 2010-04-09 |
MX2010008879A (es) | 2010-10-20 |
ZA201006549B (en) | 2011-06-29 |
RU2010137972A (ru) | 2012-03-20 |
US20100310716A1 (en) | 2010-12-09 |
WO2009102152A3 (ko) | 2009-11-26 |
EP2241199A4 (en) | 2012-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009102152A2 (ko) | 천연물을 이용한 발효물의 제조 방법 및 상기 방법에 의해 제조된 발효물을 포함하는 식품 또는 의약품 | |
CN106798252B (zh) | 一种具有调理肠胃降血脂溶血栓功效的纳豆产品 | |
CN110403073A (zh) | 一种大豆秸秆发酵饲料及其制备方法 | |
CN110353098A (zh) | 一种玉米秸秆发酵饲料及其制备方法 | |
CN110574840A (zh) | 一种预防非洲猪瘟的中药发酵饲料及其制备方法 | |
CN112913964A (zh) | 一种发酵饲料及其制备方法 | |
CN112471325A (zh) | 一种秸秆生物发酵饲料及其制备方法和应用 | |
CN117297028A (zh) | 一种低热量高饱腹感的蛋白质代餐营养棒及其制备方法 | |
CN110583855A (zh) | 一种高色氨酸发酵饲料的制备方法 | |
CN112205542A (zh) | 一种发酵型功能性精养草鱼膨化饲料及其生产工艺 | |
CN110870511A (zh) | 一种干湿混合浓缩饲料及其制备方法 | |
CN116144555A (zh) | 一种拮抗肉鸡肠道损伤的发酵饲料添加剂及其制备方法和应用 | |
CN110959746A (zh) | 一种益生菌发酵饲料及其制备方法 | |
KR20030075996A (ko) | 고초균과 효모균을 이용한 사료첨가제 및 이의 제조방법 | |
CN112674203B (zh) | 一种可降解赭曲霉毒素的微生态制剂及其制备方法 | |
CN115572691A (zh) | 一种含植物乳杆菌的水产发酵剂及其制备方法和应用 | |
CN1676022A (zh) | 一种禽类微生物二次发酵饲料的制备方法 | |
CN107981065B (zh) | 复合菌液、应用其的发酵饲料及其在制备用于改善断奶仔猪肠道健康的饲料中的应用 | |
CN110367374B (zh) | 发酵固料、发酵饲料及其制备方法 | |
CN106937711A (zh) | 一种防治仔猪水肿病的饲料及其制作方法 | |
CN113768055A (zh) | 一种降低仔猪腹泻率的低排环保型预混合饲料及其配合饲料和制备方法 | |
CN112825980A (zh) | 基于微生物发酵生产畜牧水产用含葡萄糖氧化酶功能型活性肽粉的方法 | |
CN107897505B (zh) | 发酵菌液、包含其的用于保育猪的产品及产品的制备方法和应用 | |
CN114365843B (zh) | 一种富含氨基酸的五谷酵粉及其制备方法和应用 | |
CN110897088A (zh) | 一种小麦胚芽多肽速食粉的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980104600.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09709828 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009709828 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010546695 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12865447 Country of ref document: US Ref document number: 12010501755 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 207606 Country of ref document: IL Ref document number: MX/A/2010/008879 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2714793 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: PI 2010003834 Country of ref document: MY |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009213253 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010137972 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: 2009213253 Country of ref document: AU Date of ref document: 20090212 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0907875 Country of ref document: BR Kind code of ref document: A2 Effective date: 20100816 |